Since elevated serum levels of trimethylamine N-oxide (TMAO) were first associated with
increased risk of cardiovascular disease (CVD), TMAO research among chronic diseases …

Both inflammation and smoking can influence a drug's pharmacokinetic properties, ie, its
liberation, absorption, distribution, metabolism, and elimination. Depending on, eg …

Fructose is a main dietary sugar involved in the excess sugar intake-mediated progression
of cardiovascular diseases and cardiac arrhythmias. Chronic intake of fructose has been the …

Type 2 diabetes mellitus (T2DM) is a burdensome global disease. In-depth understanding of
its mechanism will help to optimize diagnosis and treatment, which reduces the burden …

The gut microbiota (GM) plays a role in the development and progression of type 1 and type
2 diabetes mellitus (DM) and its complications. Gut dysbiosis contributes to the …

Background Subjects who have cardiovascular diseases (CVDs) share a variety of common
characteristic including increased blood pressure (BP), disrupted glycemic control, and …

Aims Hyperglycemia and insulin resistance drive intestinal barrier dysfunction in type 2
diabetes (T2DM). Vaccarin, the main active component in the semen of traditional Chinese …

Aim: This study was designed to systematically evaluate the effects of microbiota-driven
therapy on decreasing TMAO and its related metabolites. Methods and Results: PubMed …

Abstract Purpose of Review Based on the available data, it can be assumed that microbiota
is an integral part of the human body. The most heavily colonized area of the human body is …

El término “microbiota” se refiere al ecosistema de microorganismos que coloniza el tracto
gastrointestinal. Sus funciones principales son la nutrición, metabolismo, defensa y función …